AFP (α-fetoprotein) is the most commonly used serum tumour marker for the diagnosis of HCC, but a retrospective study shows that the sensitivity of AFP in clinical practice is only approximately 60%, while its specificity is 80% [5, 6]. This evidence concerns the gene AFP and hepatocellular carcinoma.